Battle Card: Latus Bio AI/ML Sales Trigger

🚀 Battle Card: Latus Bio, Inc.

• Pranam Chatterjee, Scientific Advisory Board Member · 🔗 LinkedIn

• Philip M. Kim, Scientific Advisory Board Member · 🔗 LinkedIn

• Latus Bio is layering AI/ML on the industry’s largest in vivo AAV capsid dataset to slash discovery timelines and unlock new tissue tropisms. → Source (Capitalize on this Latus Bio, Inc. sales trigger to showcase our predictive analytics advantage.)

• Slow, manual capsid screening limiting pipeline velocity

• Lack of predictive payload design tools for tissue- and cell-type specificity

• Primary: AI-driven analytics platform for AAV capsid & payload data → Accelerated design cycles & higher success rates

• Expansion: Custom ML model integration & validation services → Scalable predictive engine tuned to safety/performance

• HQ: Philadelphia, PA

• Employees: ≈ 50

• Rev: ≈ $10 M

• Website: latusbio.com (Remind prospects this Latus Bio, Inc. sales trigger is reshaping their R&D roadmap.)

🤼 Competitive Intel

• Dyno Therapeutics — AI-driven AAV capsid engineering
• Unique edge: Proprietary ML pipeline for capsid optimization
• Evaluated by VP R&D for speed-to-clinic

• Voyager Therapeutics — Gene therapy delivery solutions
• Unique edge: Deep CNS targeting & clinical experience
• Evaluated by CSO for translational safety data

• AGTC — AAV vector development
• Unique edge: Established manufacturing & regulatory track record
• Evaluated by Dir. Bioinformatics for data integration

• Engine Biosciences — Protein design & ML modeling
• Unique edge: Structural generative models for payloads
• Evaluated by Head of Computational Biology for model accuracy

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑AI-driven analytics platform for AAV capsid & payload data❑
PROOF_METRIC  = ❑30% reduction in screening time❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Pranam
COMPANY     = Latus Bio, Inc.
DEPT        = R&D
SIZE        = ≈20
BOTTLENECK  = manual capsid screening
EVENT       = AI/ML Strategy Launch
DETAIL      = AI/ML strategy and SAB additions
PAIN        = slow, manual capsid screening
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251103349850&div=41152219
SIM_CO      = Dyno Therapeutics
WIN_METRIC  = 30% faster discovery timelines
NEXT_SIZE   = ≈50
EMP_EST     = ≈50
REV_EST     = ≈$10M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈20-person R&D

Pranam—noticed your R&D team is ≈20.

That’s when manual capsid screening slows growth.

We helped Dyno Therapeutics fix this with AI-driven analytics platform for AAV capsid & payload data.

Result: 30% faster discovery timelines.  
Quick call?

PS—next bottleneck hits ≈50.

DM ≤45 words, TONE:
Saw your post about AI/ML strategy and SAB additions — slow, manual capsid screening.  
AI-driven analytics platform for AAV capsid & payload data. 30% reduction in screening time.  
Quick chat?